581 related articles for article (PubMed ID: 17277783)
1. Ubc9 fusion-directed SUMOylation (UFDS): a method to analyze function of protein SUMOylation.
Jakobs A; Koehnke J; Himstedt F; Funk M; Korn B; Gaestel M; Niedenthal R
Nat Methods; 2007 Mar; 4(3):245-50. PubMed ID: 17277783
[TBL] [Abstract][Full Text] [Related]
2. Enhanced detection of in vivo SUMO conjugation by Ubc9 fusion-dependent sumoylation (UFDS).
Niedenthal R
Methods Mol Biol; 2009; 497():63-79. PubMed ID: 19107411
[TBL] [Abstract][Full Text] [Related]
3. Ubc9 fusion-directed SUMOylation (UFDS).
Niedenthal R
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1430-2. PubMed ID: 18031239
[TBL] [Abstract][Full Text] [Related]
4. Association of Ubc9, an E2 ligase for SUMO conjugation, with p53 is regulated by phosphorylation of p53.
Lin JY; Ohshima T; Shimotohno K
FEBS Lett; 2004 Aug; 573(1-3):15-8. PubMed ID: 15327968
[TBL] [Abstract][Full Text] [Related]
5. Ubc9 fusion-directed SUMOylation identifies constitutive and inducible SUMOylation.
Jakobs A; Himstedt F; Funk M; Korn B; Gaestel M; Niedenthal R
Nucleic Acids Res; 2007; 35(17):e109. PubMed ID: 17709345
[TBL] [Abstract][Full Text] [Related]
6. Is Transthyretin a Regulator of Ubc9 SUMOylation?
Wieczorek E; Kędracka-Krok S; Sołtys K; Jankowska U; Hołubowicz R; Seliga J; Ożyhar A
PLoS One; 2016; 11(8):e0160536. PubMed ID: 27501389
[TBL] [Abstract][Full Text] [Related]
7. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation.
Wiechmann S; Gärtner A; Kniss A; Stengl A; Behrends C; Rogov VV; Rodriguez MS; Dötsch V; Müller S; Ernst A
J Biol Chem; 2017 Sep; 292(37):15340-15351. PubMed ID: 28784659
[TBL] [Abstract][Full Text] [Related]
8. Involvement of PIAS1 in the sumoylation of tumor suppressor p53.
Kahyo T; Nishida T; Yasuda H
Mol Cell; 2001 Sep; 8(3):713-8. PubMed ID: 11583632
[TBL] [Abstract][Full Text] [Related]
9. Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity.
Schmidt D; Müller S
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2872-7. PubMed ID: 11867732
[TBL] [Abstract][Full Text] [Related]
10. MEL-18 interacts with HSF2 and the SUMO E2 UBC9 to inhibit HSF2 sumoylation.
Zhang J; Goodson ML; Hong Y; Sarge KD
J Biol Chem; 2008 Mar; 283(12):7464-9. PubMed ID: 18211895
[TBL] [Abstract][Full Text] [Related]
11. SIM-dependent enhancement of substrate-specific SUMOylation by a ubiquitin ligase in vitro.
Parker JL; Ulrich HD
Biochem J; 2014 Feb; 457(3):435-40. PubMed ID: 24224485
[TBL] [Abstract][Full Text] [Related]
12. Mutually exclusive STAT1 modifications identified by Ubc9/substrate dimerization-dependent SUMOylation.
Zimnik S; Gaestel M; Niedenthal R
Nucleic Acids Res; 2009 Mar; 37(4):e30. PubMed ID: 19174562
[TBL] [Abstract][Full Text] [Related]
13. Covalent conjugation of the equine infectious anemia virus Gag with SUMO.
Wang J; Wen S; Zhao R; Qi J; Liu Z; Li W; An J; Wood C; Wang Y
Biochem Biophys Res Commun; 2017 May; 486(3):712-719. PubMed ID: 28342872
[TBL] [Abstract][Full Text] [Related]
14. The Mdm-2 amino terminus is required for Mdm2 binding and SUMO-1 conjugation by the E2 SUMO-1 conjugating enzyme Ubc9.
Buschmann T; Lerner D; Lee CG; Ronai Z
J Biol Chem; 2001 Nov; 276(44):40389-95. PubMed ID: 11384992
[TBL] [Abstract][Full Text] [Related]
15. Pellino-1, an adaptor protein of interleukin-1 receptor/toll-like receptor signaling, is sumoylated by Ubc9.
Kim JH; Sung KS; Jung SM; Lee YS; Kwon JY; Choi CY; Park SH
Mol Cells; 2011 Jan; 31(1):85-9. PubMed ID: 21120624
[TBL] [Abstract][Full Text] [Related]
16. SUMO modification of Akt regulates global SUMOylation and substrate SUMOylation specificity through Akt phosphorylation of Ubc9 and SUMO1.
Lin CH; Liu SY; Lee EH
Oncogene; 2016 Feb; 35(5):595-607. PubMed ID: 25867063
[TBL] [Abstract][Full Text] [Related]
17. SUMOylation of ATF3 alters its transcriptional activity on regulation of TP53 gene.
Wang CM; Brennan VC; Gutierrez NM; Wang X; Wang L; Yang WH
J Cell Biochem; 2013 Mar; 114(3):589-98. PubMed ID: 22991139
[TBL] [Abstract][Full Text] [Related]
18. Enhanced SUMOylation of proteins containing a SUMO-interacting motif by SUMO-Ubc9 fusion.
Kim ET; Kim KK; Matunis MJ; Ahn JH
Biochem Biophys Res Commun; 2009 Oct; 388(1):41-5. PubMed ID: 19635459
[TBL] [Abstract][Full Text] [Related]
19. Repression of Smad4 transcriptional activity by SUMO modification.
Long J; Wang G; He D; Liu F
Biochem J; 2004 Apr; 379(Pt 1):23-9. PubMed ID: 14750902
[TBL] [Abstract][Full Text] [Related]
20. PML IV/ARF interaction enhances p53 SUMO-1 conjugation, activation, and senescence.
Ivanschitz L; Takahashi Y; Jollivet F; Ayrault O; Le Bras M; de Thé H
Proc Natl Acad Sci U S A; 2015 Nov; 112(46):14278-83. PubMed ID: 26578773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]